Novartis says it is investigating claims that its eye care unit, Alcon, bribed doctors in over 200 hospitals in China to promote its lens implants.
On Tuesday, a Chinese newspaper alleged that Alcon paid doctors "research fees" through a third-party for fake clinical trials that never took place.
This is the second such allegation to be made against Novartis recently.
Last month, the 21st Century Business Herald claimed the Swiss company bribed doctors to increase drug sales.
The latest report was also carried by the same paper. Full story...
Related posts:
On Tuesday, a Chinese newspaper alleged that Alcon paid doctors "research fees" through a third-party for fake clinical trials that never took place.
This is the second such allegation to be made against Novartis recently.
Last month, the 21st Century Business Herald claimed the Swiss company bribed doctors to increase drug sales.
The latest report was also carried by the same paper. Full story...
Related posts:
- Japanese university to retract Novartis study for fabricated data...
- Novartis under fire over false Japanese drug data...
- Novartis hit by second US lawsuit in four days...
- India's Supreme Court rejects patent for cancer drug from pharma giant Novartis...
- Germany fourth country to ban Novartis flu vaccine...
- Novartis chairman’s golden payoff slammed...
- Drug giants fined $11bn for criminal wrongdoing, but fines are not enough...
- Pharma giant Pfizer fined for bribing officials in Eastern Europe and China...
No comments:
Post a Comment